PRL, prolactin, 5617

N. diseases: 506; N. variants: 3
Disease: Pituitary Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0032019
Disease: Pituitary Neoplasms
Pituitary Neoplasms 		0.330 AlteredExpression group BEFREE Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression. 12554778 2003
CUI: C0032019
Disease: Pituitary Neoplasms
Pituitary Neoplasms 		0.330 Biomarker group BEFREE The diagnosis of a pituitary tumor is made by pituitary imaging and selected hormone assays (mainly PRL). 9167954 1997
CUI: C0032019
Disease: Pituitary Neoplasms
Pituitary Neoplasms 		0.330 Therapeutic group CTD_human [Morphological changes in prolactinoma induced by bromocriptine treatment]. 2274009 1991
CUI: C0032019
Disease: Pituitary Neoplasms
Pituitary Neoplasms 		0.330 Biomarker group CTD_human [Morphological changes in prolactinoma induced by bromocriptine treatment]. 2274009 1991
CUI: C0032019
Disease: Pituitary Neoplasms
Pituitary Neoplasms 		0.330 Biomarker group BEFREE Pituitary tumors are primarily prolactin-producing tumors, and medical treatment is the method of choice. 2568165 1989
CUI: C0032019
Disease: Pituitary Neoplasms
Pituitary Neoplasms 		0.330 Biomarker group CTD_human Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study. 3498743 1987
CUI: C0032019
Disease: Pituitary Neoplasms
Pituitary Neoplasms 		0.330 Therapeutic group CTD_human Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study. 3498743 1987
CUI: C0032019
Disease: Pituitary Neoplasms
Pituitary Neoplasms 		0.330 Therapeutic group CTD_human If animals were further treated with prolactin, the development of HT and MT was accelerated, whereas that of PT was suppressed. 6156259 1980
CUI: C0032019
Disease: Pituitary Neoplasms
Pituitary Neoplasms 		0.330 Biomarker group CTD_human If animals were further treated with prolactin, the development of HT and MT was accelerated, whereas that of PT was suppressed. 6156259 1980